Welcome to our dedicated page for Icu Medical news (Ticker: ICUI), a resource for investors and traders seeking the latest updates and insights on Icu Medical stock.
ICU Medical, Inc. (Nasdaq: ICUI) is a medical technology company that publicly reports on its performance and activities through regular news releases and investor communications. The company describes itself as a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings, and it is headquartered in San Clemente, California.
The ICUI news feed on Stock Titan aggregates company announcements that cover a range of topics important to investors and industry observers. These include quarterly earnings results, updates to fiscal year guidance, and details on product line revenues across Consumables, Infusion Systems and Vital Care. ICU Medical’s earnings releases also discuss items such as gross profit, operating expenses, non-GAAP measures like adjusted EBITDA and adjusted diluted earnings per share, and commentary from management on recent performance.
In addition to financial results, ICU Medical issues news about corporate and strategic developments. Recent disclosures include the completion of Otsuka ICU Medical LLC, a joint venture with Otsuka Pharmaceutical Factory, Inc. focused on IV solutions manufacturing and innovation in North America. The company also announces its participation in major healthcare and investor conferences, such as the J.P. Morgan Healthcare Conference and events hosted by Piper Sandler, Wells Fargo and Morgan Stanley.
Through these updates, readers can follow how ICU Medical communicates its business progress, financial outlook and strategic initiatives. The ICUI news page on Stock Titan provides a centralized view of press releases related to earnings, guidance, joint ventures, conference appearances and other material events referenced in the company’s SEC filings. Investors and researchers can use this stream of information to monitor developments in ICU Medical’s infusion systems, consumables, vital care product lines and broader corporate activities over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
ICU Medical, Inc. (Nasdaq: ICUI) has announced the schedule for its first quarter 2023 earnings release and conference call. The earnings results will be published on May 8, 2023, at approximately 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. Investors can access the call by dialing (877) 300-8521 and using conference ID 10177448. A live webcast of the call will also be available on the company's website, with a replay option provided afterward.
ICU Medical is recognized globally for its infusion systems and critical care products used in varied healthcare settings, underscoring its commitment to quality and innovation.